| View |
|
DRP-12583-04
|
Omeprazole (as sodium)
|
Triasop
|
40 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
18 October 2023
|
08 September 2027
|
| View |
|
DRP-12591-01
|
Cefixime (as trihydrate)
|
Cefiden
|
100 mg /5 mL (20 mg/mL)
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
22 October 2023
|
19 September 2027
|
| View |
|
DRP-12736-04
|
Telmisartan + Amlodipine (as besilate)
|
Telarb CCB
|
40 mg / 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
30 September 2027
|
| View |
|
DRP-12737-01
|
Telmisartan + Amlodipine (as besilate)
|
Telarb CCB
|
80 mg / 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
19 October 2023
|
30 September 2027
|
| View |
|
DRP-12738-03
|
Telmisartan + Amlodipine (as besilate)
|
Telmix 45
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
30 September 2027
|
| View |
|
DRP-13341-02
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/ 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Film Coated Tablet
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories
|
Philippines
|
CLIDP Conversion
|
23 October 2023
|
31 January 2028
|
| View |
|
DRP-13391-01
|
Bleomycin (as sulfate)
|
Bleonov
|
15 Units
|
Powder for Solution for Injection (IM/IV/SC)
|
Antineoplastic agent
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
23 October 2023
|
16 February 2028
|
| View |
|
DRP-13547-01
|
Ciprofloxacin (as Lactate)
|
None
|
2 mg / mL
|
Solution for Injection (I.V.)
|
Antibacterial (Quinolone)
|
Bosch Pharmaceuticals (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
19 October 2023
|
29 September 2026
|
| View |
|
DRP-13676-01
|
Omeprazole (as sodium)
|
Premio
|
40 mg
|
Lyophilized Powder for I.V. Infusion
|
Proton Pump Inhibitor
|
Bosch Pharmaceuticals (Pvt.) Ltd
|
Pakistan
|
Renewal
|
17 May 2024
|
09 July 2029
|
| View |
|
DRP-13699-01
|
Piperacillin (as Sodium) / Tazobactam (as sodium)
|
Unbranded
|
4.5 gram
|
Powder for injection (I.V.)
|
Antibacterial (Penicillin)
|
Bosch Pharmaceuticals (Pvt.) Ltd
|
Pakistan
|
Renewal
|
19 June 2024
|
13 July 2029
|
| View |
|
DRP-13818-01
|
Ceftriaxone Sodium
|
None
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
18 October 2023
|
02 October 2028
|
| View |
|
DRP-13847-01
|
Glimepiride
|
Glypride
|
3 mg
|
Tablet
|
Oral Hypoglycemic Agent (Sulfonylurea)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 October 2023
|
06 June 2028
|
| View |
|
DRP-13848-01
|
Glimepiride
|
Glypride
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent (Sulfonylurea)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 October 2023
|
06 June 2028
|
| View |
|
DRP-14046-01
|
Cetirizine (as hydrochloride)
|
None
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 October 2023
|
08 June 2028
|
| View |
|
DRHR-2021
|
Menthol
|
Koolex patch
|
260mg
|
Transdermal Patch
|
-
|
Jeil Health Science, Inc.
|
Korea
|
Initial [HR]
|
21 June 2021
|
21 June 2026
|
| View |
|
DRP-14399
|
Montelukast (as sodium)
|
None
|
4 mg
|
Chewable Tablet
|
-
|
Aurobindo Pharma Limited Unit VII
|
India
|
Initial (Re-application)
|
31 August 2023
|
31 August 2026
|
| View |
|
DRP-14331
|
Docetaxel
|
Taxwell-RTU
|
20 mg/mL (80 mg/4 mL)
|
Solution for Infusion (I.V.)
|
-
|
Getwell Pharmaceuticals
|
India
|
Initial
|
23 August 2023
|
23 August 2028
|
| View |
|
DRP-14226-01
|
Rosuvastatin (as calcium)
|
Searosu
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 October 2023
|
28 October 2027
|
| View |
|
DRP-1587-04
|
Glimepiride
|
Glypostad
|
3 mg
|
Tablet
|
Oral Hypoglycemic (Sulfonylurea)
|
Lek S.A
|
Poland
|
CLIDP Conversion
|
23 October 2023
|
19 December 2028
|
| View |
|
DRP-1588-04
|
Glimepiride
|
Glypostad
|
2 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Lek S.A
|
Poland
|
CLIDP Conversion
|
18 October 2023
|
19 December 2028
|